YOLFTbeta
Hantech Bio-Technology Co., Ltd.

Hantech Bio-Technology Co., Ltd.

1294 · TWO · Consumer Defensive / Packaged Foods

44.10TWD+0.05 (+0.11%)

Price History

Full chart

Market Stats

Previous Close44.05
Open44.05
Day Range43.95 – 44.20
52-Week Range49.30 – 75.82
Volume14.92K
Market Cap1.81B
P/E (TTM)12.28
Forward P/E0.00
EPS4.05
Dividend Yield5.98%
Beta-0.26
50-Day Avg54.15
200-Day Avg62.74

About

Hantech Bio-Technology Co., Ltd., through its subsidiaries, engages in the manufacture, trade in, and distributes biotech foods, health foods, and Traditional Chinese Medicine skincare and beauty products in Taiwan and internationally. The company offers OEM & ODM manufacturer of liquid, jelly, and gel-type health supplements. It also provides aluminum foil bag designs; and aluminum foil-packaged beverage production activities. In addition, the company is involved in the manufacture of machinery and equipment; and trade in of health food raw materials. It serves clients across both online and offline channels, including direct sales, micro-businesses, physical stores (pharmacies/drugstores/beauty shops), TV, radio, telemarketing centers, TV shopping, online shopping, and live-stream shopping. Hantech Bio-Technology Co., Ltd. was founded in 2007 and is based in Changhua, Taiwan.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEOXie Junyang
  • Employees0
  • HeadquartersNo. 101, Gongye Rd., Changhua, Taiwan, 514, Taiwan
  • Websitehttps://www.htbios.com

Leadership

  • Xie JunyangChief Financial Officer
  • Geng Hao LiuAccounting Supervisor
  • Mr. Laien LiDeputy GM of General Administration Office
  • Ms. Yuxuan LiChief of Audit Section
  • Mr. Qihao LiuTreasurer
  • Mr. Bizhen YangDeputy GM of Quality Assurance Department

Financials

Income Statement

Currency: TWD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue240.29M302.52M625.14M748.42M778.54M
Growth (%)-+25.89%+106.65%+19.72%+4.02%
Cost of Revenue139.27M175.88M344.29M442.68M489.65M
Gross Profit101.03M126.63M280.85M305.74M288.89M
Gross Margin42.04%41.86%44.93%40.85%37.11%
Operating Expense62.41M69.19M95.71M108.30M115.34M
Operating Income38.62M57.44M185.14M197.44M173.55M
Operating Margin16.07%18.99%29.62%26.38%22.29%
EBITDA-78.52M207.63M232.09M214.16M
EBITDA Margin-25.96%33.21%31.01%27.51%
Net Income32.56M47.47M148.12M155.67M139.05M
Net Income Margin13.55%15.69%23.69%20.80%17.86%
R&D6.90M8.09M7.37M10.13M12.18M
R&D as % of Total Revenue2.87%2.67%1.18%1.35%1.56%
Interest Expense1.55M1.47M2.12M5.38M2.98M
Interest Expense % of Total Revenue0.64%0.49%0.34%0.72%0.38%

Balance Sheet

Currency: TWD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets375.65M473.59M930.94M1.12B1.17B
Total Liabilities197.74M205.02M529.56M298.18M334.10M
Total Equity174.62M266.89M398.09M817.78M829.16M
Cash86.41M75.04M167.09M382.42M249.40M
Net Debt27.96M10.44M118.01M--

Cash Flow

Currency: TWD2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow44.39M63.18M191.91M150.75M160.63M
Capital Expenditure80.31M83.61M297.22M25.39M16.72M
Free Cash Flow-35.93M-20.44M-105.31M125.36M143.91M
Dividends Paid8.06M-16.84M19.41M87.43M
FCF to OCF-80.94%-32.35%-54.88%83.16%89.59%
Dividend Paid to FCF-22.43%--15.99%15.49%60.75%

Earnings

Report DateNov 14, 2024Mar 31, 2025
EPS Estimate1.441.26
EPS Actual1.490.81
Surprise3.47%-35.71%
TimingPre-marketPre-market

Key Statistics & Ratios

Market Cap1.81B
Enterprise Value1.56B
Trailing P/E12.28
Forward P/E0.00
Price / Sales2.09
Price / Book2.25
EPS4.05
Book Value22.55
Revenue (TTM)864.73M
Gross Profit (TTM)310.04M
EBITDA212.45M
Profit Margin17.25%
Operating Margin20.46%
Return on Equity18.35%
Return on Assets9.45%
Shares Outstanding36.33M
Shares Float15.92M
Beta-0.26
Dividend Yield5.98%
Dividend Rate3.00
Payout Ratio132.64%

Dividends

20261×
3.00Jul 3, 2026
20251×
2.37Jul 15, 2025
20241×
0.58Jun 6, 2024
20231×
0.58Jul 7, 2023

Stock Splits

  • Jul 3, 20261200:1000
  • Jul 31, 20251100.823:1000
  • Jun 6, 20241300:1000
  • Jul 7, 20231150:1000